Key terms

About EVH

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest EVH news

Apr 17 7:21am ET Analysts’ Top Healthcare Picks: Evolent Health (EVH), Nurix Therapeutics (NRIX) Apr 15 7:20am ET Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Walgreens Boots Alliance (WBA) and Evolent Health (EVH) Apr 05 6:40am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Blueprint Medicines (BPMC) and Evolent Health (EVH) Mar 28 6:41am ET Evolent Health price target lowered to $44 from $45 at Canaccord Mar 05 7:26am ET Evolent Health (EVH) Gets a Hold from Truist Financial Mar 01 9:46am ET GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls Mar 01 7:27am ET Evolent Health initiated with an Outperform at Oppenheimer Feb 26 7:17am ET Truist Financial Remains a Hold on Evolent Health (EVH) Feb 23 9:47am ET Evolent Health rises 9.2% Feb 23 7:48am ET Evolent Health Outperforms with Strong Q4 Results and Promising Growth Outlook: A Buy Rating from Analyst David Larsen Feb 23 7:21am ET Piper Sandler Reaffirms Their Buy Rating on Evolent Health (EVH) Feb 23 7:19am ET Evolent Health (EVH) Receives a Buy from RBC Capital Feb 23 7:15am ET Evolent Health price target lowered to $45 from $47 at Canaccord Feb 23 6:54am ET Evolent Health files to sell Class A common stock, no amount given Feb 23 6:23am ET Evolent Health price target raised to $38 from $37 at JMP Securities Feb 23 3:16am ET Barclays Reaffirms Their Buy Rating on Evolent Health (EVH) Feb 23 12:40am ET Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Evolent Health (EVH) Feb 22 11:45pm ET Evolent Health (EVH) Buy Rating Affirmed Amid Strong Q4 Results and Promising 2024 Projections Feb 22 4:13pm ET Evolent Health sees FY24 revenue $2.4B-$2.5B, consensus $2.32B Feb 22 4:12pm ET Evolent Health sees Q1 revenue $595M-$610M, consensus $552.49M Feb 15 3:10am ET Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Evolent Health (EVH) and InMode (INMD) Feb 14 4:38pm ET Evolent Health Board Changes and Upcoming Virtual Meeting Feb 07 7:32am ET RBC Capital Sticks to Their Buy Rating for Evolent Health (EVH)

No recent press releases are available for EVH

EVH Financials

1-year income & revenue

Key terms

EVH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

EVH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms